Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1Genitourinary 1Gastrointestinal 1Dermatologic 1CNS 1

Conditions

Keratosis, Actinic 12Melanoma 2Keratosis 2Carcinoma, Basal Cell 2Wilms Tumor 1Sarcoma, Ewing 1Rhabdomyosarcoma 1Osteosarcoma 1Neuroblastoma 1Hepatoblastoma 1Eyelid Neoplasms 1Carcinoma, Squamous Cell 1Carcinoma, Hepatocellular 1Bowen's Disease 1Adenocarcinoma, Sebaceous 1

Interventions

Nivolumab 3fludarabine 2tipifarnib 1pembrolizumab 1humanized 3F8 anti-GD2 monoclonal antibody 1fludarabine phosphate 1bempegaldesleukin 1X-Rays 1Stem Cell Transplantation 1Specimen Handling 1Sirolimus 1Phantoms, Imaging 1Mesna 1Melphalan 1Ipilimumab 1Imatinib Mesylate 1Cyclophosphamide 1Cryotherapy 1Cryosurgery 1Busulfan 1Bone Density 1Alemtuzumab 1Albumin-Bound Paclitaxel 1Absorptiometry, Photon 1130-nm albumin-bound paclitaxel 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Sarcoma, Ewing × Cryotherapy × Dermatologic × Clear all
NCT05302921 2025-01-01

Neoadjuvant Dual Checkpoint Inhibition and Cryoablation in Relapsed/Refractory Pediatric Solid Tumors

Children's National Research Institute

Phase 2 Completed
5 enrolled
CNSDermatologicGastrointestinalGenitourinarySarcoma

Carcinoma, Hepatocellular, Melanoma, Wilms Tumor, Neuroblastoma, Rhabdomyosarcoma, Sarcoma, Ewing, Osteosarcoma, Hepatoblastoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡